SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001477932-24-006615 from DP Cap Acquisition Corp I (DPCS, DPCSU, DPCSW) (CIK 0001857803)

DP Cap Acquisition Corp I (DPCS, DPCSU, DPCSW) (CIK 0001857803)
Date: Oct. 22, 2024 · CIK: 0001857803 · Accession: 0001477932-24-006615

AI Filing Summary & Sentiment

File numbers found in text: 001-41041

Referenced dates: October 22, 2024

Date
October 22, 2024
Author
/s/ Jason Hyatt
Form
CORRESP
Company
DP Cap Acquisition Corp I (DPCS, DPCSU, DPCSW) (CIK 0001857803)

Letter

dpcs_corresp.htm

99 Bishopsgate

London EC2M 3XF

United Kingdom

Tel: +44(0)20.7710.1000 Fax: +44(0)20.7374.4460

www.lw.com

FIRM / AFFILIATE OFFICES

October 22, 2024

Austin

Beijing

Boston

Brussels

Century City

Chicago

Dubai

Düsseldorf

Frankfurt

Hamburg

Hong Kong

Houston

London

Los Angeles

Madrid

Milan

Moscow

Munich

New York

Orange County

Paris

Riyadh*

San Diego

San Francisco

Seoul

Shanghai

Silicon Valley

Singapore

Tel Aviv

Tokyo

Washington, D.C.

VIA EDGAR

United States Securities and Exchange Commission

Division of Corporation Finance

Office of Real Estate & Construction

100 F Street, N.E.

Washington, D.C. 20549-6010

Attention:

Ruairi Regan

Dorrie Yale

Re:

DP Cap Acquisition Corp I

Preliminary Proxy Statement on Schedule 14A

Filed October 15, 2024

File No. 001-41041

Ladies and Gentlemen:

On behalf of our client, DP Cap Acquisition Corp I (the “Company”), we are submitting this letter in response to the comment received from the staff (the “Staff”) of the Securities and Exchange Commission (the “SEC”) by letter, dated October 22, 2024 (the “Comment Letter”), regarding the Company’s Preliminary Proxy Statement on Schedule 14A (the “Preliminary Proxy Statement”), as filed with the SEC on October 15, 2024.

Concurrently with this letter, the Company is filing a revised Preliminary Proxy Statement on Schedule 14A, which has been revised to reflect the Company’s response to the Comment Letter, as well as certain other changes.

For ease of review, we have set forth below the Staff’s comment in bold type, followed by the Company’s response thereto. Unless otherwise indicated, capitalized terms used herein have the meanings assigned to them in the revised Preliminary Proxy Statement and all references to page numbers in such response are to page numbers in the revised Preliminary Proxy Statement.

Latham & Watkins is the business name of Latham & Watkins (London) LLP, a registered limited liability partnership organised under the laws of New York and authorised and regulated by the Solicitors Regulation Authority (SRA No. 203820). A list of the names of the partners of Latham & Watkins (London) LLP is open to inspection at its principal place of business, 99 Bishopsgate, London EC2M 3XF, and such persons are either solicitors, registered foreign lawyers, or managers authorised by the SRA. We are affiliated with the firm Latham & Watkins LLP, a limited liability partnership organised under the laws of Delaware.

*In cooperation with the Law Firm of Salman M. Al-Sudairi LLC

October 22, 2024

Page 2

General

We note that you are seeking to extend your termination date from November 12, 2024 to an undetermined date in 2025, a date which is more than 36 months from your initial public offering. We also note that you are currently listed on Nasdaq and your statement that Nasdaq "could" seek to suspend and delist your securities from its exchange at the end of the 36-month period. We also note that Nasdaq Rule 5815 was amended effective October 7, 2024 to provide for the immediate suspension and delisting upon issuance of a delisting determination letter for failure to meet the requirement in Nasdaq Rule IM 5101-2(b) to complete one or more business combinations within 36 months of the date of effectiveness of its IPO registration statement. Please revise to state that your securities will face immediate suspension and delisting action once you receive a delisting determination letter from Nasdaq after the 36-month window ends on November 8, 2024. Please disclose the risks of non-compliance with this rule, including that under the new framework, Nasdaq may only reverse the determination if it finds it made a factual error applying the applicable rule. In addition, please also expand on your discussion of the consequences of any such suspension or delisting, including any potential impact on your ability to complete an initial business combination, any impact on the market for your securities including demand for your securities, and any impact on securities holders due to your securities no longer being considered “covered securities.”

Response: The Staff’s comment is duly noted and we have revised the disclosure in the Preliminary Proxy Statement as requested.

* * *

We hope the foregoing answer is responsive to your comment. Please do not hesitate to contact me by telephone at +44.20.7710.1169 with any questions or comments regarding this correspondence.

Very truly yours,
/s/ Jason Hyatt

Show Raw Text
CORRESP
1
filename1.htm

dpcs_corresp.htm

   99 Bishopsgate

 London EC2M 3XF

 United Kingdom

 Tel: +44(0)20.7710.1000  Fax: +44(0)20.7374.4460

 www.lw.com

   FIRM / AFFILIATE OFFICES

   October 22, 2024

   Austin

 Beijing

 Boston

 Brussels

 Century City

 Chicago

 Dubai

 Düsseldorf

 Frankfurt

 Hamburg

 Hong Kong

 Houston

 London

 Los Angeles

 Madrid

 Milan

   Moscow

 Munich

 New York

 Orange County

 Paris

 Riyadh*

 San Diego

 San Francisco

 Seoul

 Shanghai

 Silicon Valley

 Singapore

 Tel Aviv

 Tokyo

 Washington, D.C.

 VIA EDGAR

 United States Securities and Exchange Commission

 Division of Corporation Finance

 Office of Real Estate & Construction

 100 F Street, N.E.

 Washington, D.C. 20549-6010

     Attention:

   Ruairi Regan

   Dorrie Yale

   Re:

   DP Cap Acquisition Corp I

   Preliminary Proxy Statement on Schedule 14A

 Filed October 15, 2024

 File No. 001-41041

 Ladies and Gentlemen:

 On behalf of our client, DP Cap Acquisition Corp I (the “Company”), we are submitting this letter in response to the comment received from the staff (the “Staff”) of the Securities and Exchange Commission (the “SEC”) by letter, dated October 22, 2024 (the “Comment Letter”), regarding the Company’s Preliminary Proxy Statement on Schedule 14A (the “Preliminary Proxy Statement”), as filed with the SEC on October 15, 2024.

 Concurrently with this letter, the Company is filing a revised Preliminary Proxy Statement on Schedule 14A, which has been revised to reflect the Company’s response to the Comment Letter, as well as certain other changes.

 For ease of review, we have set forth below the Staff’s comment in bold type, followed by the Company’s response thereto. Unless otherwise indicated, capitalized terms used herein have the meanings assigned to them in the revised Preliminary Proxy Statement and all references to page numbers in such response are to page numbers in the revised Preliminary Proxy Statement.

 Latham & Watkins is the business name of Latham & Watkins (London) LLP, a registered limited liability partnership organised under the laws of New York and authorised and regulated by the Solicitors Regulation Authority (SRA No. 203820).  A list of the names of the partners of Latham & Watkins (London) LLP is open to inspection at its principal place of business, 99 Bishopsgate, London EC2M 3XF, and such persons are either solicitors, registered foreign lawyers, or managers authorised by the SRA.  We are affiliated with the firm Latham & Watkins LLP, a limited liability partnership organised under the laws of Delaware.

 *In cooperation with the Law Firm of Salman M. Al-Sudairi LLC

     October 22, 2024

 Page 2

 General

 We note that you are seeking to extend your termination date from November 12, 2024 to an undetermined date in 2025, a date which is more than 36 months from your initial public offering. We also note that you are currently listed on Nasdaq and your statement that Nasdaq "could" seek to suspend and delist your securities from its exchange at the end of the 36-month period. We also note that Nasdaq Rule 5815 was amended effective October 7, 2024 to provide for the immediate suspension and delisting upon issuance of a delisting determination letter for failure to meet the requirement in Nasdaq Rule IM 5101-2(b) to complete one or more business combinations within 36 months of the date of effectiveness of its IPO registration statement. Please revise to state that your securities will face immediate suspension and delisting action once you receive a delisting determination letter from Nasdaq after the 36-month window ends on November 8, 2024. Please disclose the risks of non-compliance with this rule, including that under the new framework, Nasdaq may only reverse the determination if it finds it made a factual error applying the applicable rule. In addition, please also expand on your discussion of the consequences of any such suspension or delisting, including any potential impact on your ability to complete an initial business combination, any impact on the market for your securities including demand for your securities, and any impact on securities holders due to your securities no longer being considered “covered securities.”

 Response: The Staff’s comment is duly noted and we have revised the disclosure in the Preliminary Proxy Statement as requested.

 * * *

 We hope the foregoing answer is responsive to your comment. Please do not hesitate to contact me by telephone at +44.20.7710.1169 with any questions or comments regarding this correspondence.

        Very truly yours,

     /s/ Jason Hyatt

   Jason Hyatt

 of LATHAM & WATKINS LLP

     cc:

   Scott Savitz, Chairman and Chief Executive Officer, 10X Capital Venture Acquisition Corp. II